Related content

Interleukin‐7 Enhances the Th1 Response to Promote the Development of Sjögren's Syndrome–like Autoimmune Exocrinopathy in Mice

By  

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 2132-2142

John Wiley & Sons Inc

Access to resources Recommend Favorite

The IL-7/IL-7 Receptor Axis: Understanding its Central Role in T-Cell Homeostasis and the Challenges Facing its Utilization as a Novel Therapy

By  

Current Drug Targets, Vol. 7, Iss. 12, 2006-12 ,pp. : 1571-1582

Bentham Science Publishers

Access to resources Recommend Favorite

Sjögren's syndrome

By Amarasena Roshan   Bowman Simon  

Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. : 53-56

Royal College Of Physicians

Access to resources Recommend Favorite

The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

The P2X₇ receptor as a therapeutic target

By Romagnoli Romeo   Baraldi Pier Giovanni   Cruz-Lopez Olga   Lopez-Cara Carlota   Preti Delia   Borea Pier Andrea   Gessi Stefania  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 647-661

Informa Healthcare

Access to resources Recommend Favorite